LWM
TWST icon

Lodestone Wealth Management’s Twist Bioscience TWST Stock Holding History

Lodestone Wealth Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.12K Sell
40
-250
-86% -$16.3K ﹤0.01% 615
2026
Q1 		$13.8K Hold
290
– – 0.01% 465
2025
Q4 		$9.2K Buy
+290
New +$9.05K ﹤0.01% 521

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Lodestone Wealth Management's TWST Position: Q2 2026 in Review

Lodestone Wealth Management reduced its Twist Bioscience (TWST) stake by 86% in Q2 2026, selling an estimated $16.3K and leaving 40 shares worth $4.12K. The position accounts for ﹤0.01% of the portfolio, ranked #615.

Lodestone Wealth Management first reported a position in TWST in Q4 2025 and has held it in 3 quarters since. The position peaked at $13.8K in Q1 2026. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Lodestone Wealth Management held 40 shares of Twist Bioscience worth $4.12K as of Q2 2026.
  • Lodestone Wealth Management sold 250 Twist Bioscience shares in Q2 2026, an estimated $16.3K.
  • Twist Bioscience made up ﹤0.01% of Lodestone Wealth Management's portfolio in Q2 2026, its #615 holding.
  • Lodestone Wealth Management first reported a position in Twist Bioscience in Q4 2025 and has held it in 3 quarters since.
  • Lodestone Wealth Management's Twist Bioscience position peaked at $13.8K in Q1 2026.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Lodestone Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.